| pubmed-article:10851379 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10851379 | lifeskim:mentions | umls-concept:C0026769 | lld:lifeskim |
| pubmed-article:10851379 | lifeskim:mentions | umls-concept:C0376562 | lld:lifeskim |
| pubmed-article:10851379 | lifeskim:mentions | umls-concept:C1517205 | lld:lifeskim |
| pubmed-article:10851379 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
| pubmed-article:10851379 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:10851379 | pubmed:dateCreated | 2000-7-13 | lld:pubmed |
| pubmed-article:10851379 | pubmed:abstractText | Four of 10 patients who were enrolled on protocols of high-dose immunosuppression with peripheral blood stem cell rescue for MS experienced neurologic worsening while receiving recombinant human granulocyte colony-stimulating factor. There was improvement when methylprednisolone was given to three of the patients, but one patient died of respiratory failure. The mechanism of the neurologic worsening is uncertain. | lld:pubmed |
| pubmed-article:10851379 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10851379 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10851379 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10851379 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10851379 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:10851379 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10851379 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10851379 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10851379 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10851379 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10851379 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:10851379 | pubmed:issn | 0028-3878 | lld:pubmed |
| pubmed-article:10851379 | pubmed:author | pubmed-author:OpenshawHH | lld:pubmed |
| pubmed-article:10851379 | pubmed:author | pubmed-author:AntelJ PJP | lld:pubmed |
| pubmed-article:10851379 | pubmed:author | pubmed-author:WeinerL PLP | lld:pubmed |
| pubmed-article:10851379 | pubmed:author | pubmed-author:NashRR | lld:pubmed |
| pubmed-article:10851379 | pubmed:author | pubmed-author:FormanSS | lld:pubmed |
| pubmed-article:10851379 | pubmed:author | pubmed-author:McSweeneyPP | lld:pubmed |
| pubmed-article:10851379 | pubmed:author | pubmed-author:KashyapAA | lld:pubmed |
| pubmed-article:10851379 | pubmed:author | pubmed-author:LundB TBT | lld:pubmed |
| pubmed-article:10851379 | pubmed:author | pubmed-author:StuveOO | lld:pubmed |
| pubmed-article:10851379 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10851379 | pubmed:day | 13 | lld:pubmed |
| pubmed-article:10851379 | pubmed:volume | 54 | lld:pubmed |
| pubmed-article:10851379 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10851379 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10851379 | pubmed:pagination | 2147-50 | lld:pubmed |
| pubmed-article:10851379 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:10851379 | pubmed:meshHeading | pubmed-meshheading:10851379... | lld:pubmed |
| pubmed-article:10851379 | pubmed:meshHeading | pubmed-meshheading:10851379... | lld:pubmed |
| pubmed-article:10851379 | pubmed:meshHeading | pubmed-meshheading:10851379... | lld:pubmed |
| pubmed-article:10851379 | pubmed:meshHeading | pubmed-meshheading:10851379... | lld:pubmed |
| pubmed-article:10851379 | pubmed:meshHeading | pubmed-meshheading:10851379... | lld:pubmed |
| pubmed-article:10851379 | pubmed:meshHeading | pubmed-meshheading:10851379... | lld:pubmed |
| pubmed-article:10851379 | pubmed:meshHeading | pubmed-meshheading:10851379... | lld:pubmed |
| pubmed-article:10851379 | pubmed:meshHeading | pubmed-meshheading:10851379... | lld:pubmed |
| pubmed-article:10851379 | pubmed:meshHeading | pubmed-meshheading:10851379... | lld:pubmed |
| pubmed-article:10851379 | pubmed:meshHeading | pubmed-meshheading:10851379... | lld:pubmed |
| pubmed-article:10851379 | pubmed:meshHeading | pubmed-meshheading:10851379... | lld:pubmed |
| pubmed-article:10851379 | pubmed:meshHeading | pubmed-meshheading:10851379... | lld:pubmed |
| pubmed-article:10851379 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10851379 | pubmed:articleTitle | Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor. | lld:pubmed |
| pubmed-article:10851379 | pubmed:affiliation | Department of Neurology, City of Hope National Medical Center, Duarte, CA 91010, USA. hopenshaw@coh.org | lld:pubmed |
| pubmed-article:10851379 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10851379 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10851379 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10851379 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10851379 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10851379 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10851379 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10851379 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10851379 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10851379 | lld:pubmed |
